- Details
- Description
Strength:
Niraparib 100 mg
Composition:
Niraparib Tosylate Monohydrate equivalent to Niraparib 100 mg
Treatment:
Ovarian, fallopian tube & primary peritoneal cancers
Form:
Capsule
Brand:
Niranib
Quantity Unit:
Capsules
Manufacturer:
Everest Pharmaceuticals Ltd.
Niranib 100 mg is an oral targeted anticancer medicine containing niraparib, a PARP inhibitor. It works by blocking PARP enzymes involved in DNA repair, helping prevent the growth and survival of certain cancer cells. Niraparib is used in the treatment and maintenance treatment of certain ovarian, fallopian tube, and primary peritoneal cancers, according to the applicable indication and physician's assessment.
Niranib (Niraparib Tosylate Monohydrate equivalent to Niraparib 100 mg) is an oral PARP inhibitor used in the treatment of certain ovarian, fallopian tube, and primary peritoneal cancers.
